Docoh
Loading...

HROW Harrow Health

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On June 3, 2021, the Company held the Annual Meeting at 102 Woodmont Blvd., Suite 610, Nashville, Tennessee 37205. The number of shares of common stock entitled to vote at the Annual Meeting was 25,983,666. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 20,600,874. All matters submitted to a binding vote of stockholders at the Annual Meeting were approved. The number of votes cast for and against, and the number of abstentions and broker non-votes with respect to the matters voted upon at the Annual Meeting, are set forth below:



Proposal 1: Election of Directors



Stockholders voted to elect to the Board of Directors the five (5) director nominees named in the Company’s proxy statement to serve until the 2022 annual meeting of stockholders or until their successors are duly elected and qualified. The results of the voting were:



DirectorsForWithheldBroker Non-Vote
Mark L. Baum15,881,77983,2524,635,843
Richard L. Lindstrom14,072,2311,892,8004,635,843
Robert J. Kammer13,576,1722,388,8594,635,843
Teresa F. Sparks15,057,886907,1454,635,843
R. Lawrence Van Horn15,874,42590,6064,635,843




Proposal 2: Ratification of Auditors



Stockholders ratified the selection of KMJ Corbin & Company, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of the voting were:



ForAgainstAbstainBroker Non-Vote
20,353,99084,972161,912-




Proposal 3: To approve an amendment to the Harrow Health, Inc. 2017 Incentive Stock and Awards Plan.



Stockholders approved an amendment to the Company’s 2017 Incentive Stock and Awards Plan. The results of the voting were:



ForAgainstAbstainBroker Non-Vote
12,632,0363,196,329136,6664,635,843




Proposal 4: To approve on an advisory basis, the compensation of the Company’s named executive officers.



Stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The results of the voting were:



ForAgainstAbstainBroker Non-Vote
14,781,072600,632583,3274,635,843